Skip to main content

N/A

ADVERTISEMENT
Identification
Molecular formula
C22H39N3O6
CAS number
143220-08-8
IUPAC name
2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[1-[2-(hydroxymethyl)pyrrolidine-1-carbonyl]-2-methyl-propyl]heptanamide
State
State

The compound exists as a solid at room temperature. It is generally stable under normal conditions, though it should be handled in well-ventilated areas to prevent the accumulation of any dust particles that may pose health risks if inhaled.

Melting point (Celsius)
136.00
Melting point (Kelvin)
409.15
Boiling point (Celsius)
486.40
Boiling point (Kelvin)
759.50
General information
Molecular weight
486.61g/mol
Molar mass
486.6060g/mol
Density
1.0621g/cm3
Appearence

This compound typically presents as a white to off-white solid, often appearing in the form of crystalline powder. The color and texture may vary slightly depending on impurities and processing conditions, but it is most commonly seen without coloring.

Comment on solubility

Solubility of 2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[1-[2-(hydroxymethyl)pyrrolidine-1-carbonyl]-2-methyl-propyl]heptanamide

The solubility of the compound 2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[1-[2-(hydroxymethyl)pyrrolidine-1-carbonyl]-2-methyl-propyl]heptanamide (C22H39N3O6) can be discussed based on its chemical structure, which includes multiple functional groups that influence solubility.


Key factors affecting its solubility include:

  • Hydrogen Bonding: The presence of hydroxyl (-OH) and amino (-NH2) groups can enhance the solubility in polar solvents like water due to hydrogen bonding.
  • Hydrophobic Regions: The heptanamide and propenyl components introduce hydrophobic characteristics, which may reduce solubility in highly polar solvents.
  • Ionic Interactions: If the compound can ionize under certain conditions, this could significantly enhance solubility in aqueous solutions.
  • pH Sensitivity: Changes in pH can alter the ionization state of the amino and hydroxyl groups, affecting solubility.

In summary, the solubility of this compound will largely depend on the solvent used and external conditions such as temperature and pH. As with many organic compounds, it is essential to consider the balance of polar and non-polar regions within its molecular structure.

Interesting facts

Exploring the Compound 2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[1-[2-(hydroxymethyl)pyrrolidine-1-carbonyl]-2-methyl-propyl]heptanamide

This intriguing compound is a part of a broader family known as amides, which are derivatives of carboxylic acids where the hydroxyl group is replaced with an amine group. Below are some engaging insights into this complex molecule:

  • Pharmaceutical Relevance: Compounds of this nature often serve as crucial intermediates in pharmaceutical development, especially in designing antibiotics and other therapeutic agents.
  • Structural Complexity: The structure includes both a pyrrolidine ring and a hydroxymethyl group, contributing to its unique physical and chemical properties. The presence of nitrogen atoms indicates potential for hydrogen bonding, which may influence solubility and reactivity.
  • Biological Importance: Amides are commonly found in biological systems, playing significant roles in metabolism. Their connectivity can affect biological activity, making them important in biochemistry and medicinal chemistry.
  • Potential Applications: Research suggests that similar compounds may demonstrate activities like anti-inflammatory and antimicrobial properties, indicating potential uses in medical therapies and treatments.

In summary, this compound's complex structure not only makes it a fascinating subject of study within organic chemistry but also highlights its potential implications in medicinal applications. Understanding such compounds can lead to breakthroughs in drug development and enhanced therapeutic techniques.

Synonyms
(-)-actinonin
13434-13-4
3-[[1-[(2-(Hydroxymethyl)-1-pyrrolidinyl)carbonyl]-2-methylpropyl]carbamoyl]octanohydroxamic acid
CHEMBL67311
MLS002153199
N'-hydroxy-N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-pentylbutanediamide
SMR001230684
Actinonin?
cid_2020
MLS002207060
SCHEMBL123273
BCBcMAP01_000214
IAC-4157-PI
DTXSID00864402
HMS2233D24
HMS3372O02
HMS3743O15
HMS3751M09
HMS3865F13
N*4*-Hydroxy-N*1*-[1-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-pentyl-succinamide
BDBM50035245
MFCD00080257
AKOS030241456
FA17212
SMP1_000006
LS-14745
(2R)-N4-Hydroxy-N1-[(1S)-1-[[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-2-pentyl-butanediamide
Butanediamide,n4-hydroxy-n1-[(1S)-1-[[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-2-pentyl-,(2R)-
N~4~-Hydroxy-N~1~-{1-[2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}-2-pentylbutanediamide
N4-hydroxy-N1-(1-(2-(hydroxymethyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylsuccinamide